Latigo Biotherapeutics Inc.
NASDAQ:LTGOMedical - Pharmaceuticals
Healthcare
$13.31 +5.43%
+$0.76 today
- Market cap
- $800.64M
- Beta
- 0.00
52W Low $13.50High $25.93
Volume 0.21M
Average 0.38M
Income Statement
Follow revenue through to earnings.
Revenue
—
Operating Income
—
Net Income
—
Income Statement
Currency unavailable
LTGO Earnings Waterfall · TTM
NASDAQ:LTGO · Revenue to Net Income
No earnings data available.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| SC 13G | SC 13G filing | Nov 13, 2026 | |
| SC 13G/A | SC 13G/A filing | Nov 6, 2026 | |
| 10-Q | Quarterly report | Nov 5, 2026 | |
| 8-K | Current report | Nov 5, 2026 | |
| SC 13G | SC 13G filing | Oct 29, 2026 |
Continue the stock analysis
Jump to another research area for this company.